Optimal antiarrhythmic drug therapy for electrical storm
Author(s) -
Dan Sorajja,
Thomas M. Munger,
Win-Kuang Shen
Publication year - 2015
Publication title -
journal of biomedical research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.617
H-Index - 31
eISSN - 2352-4685
pISSN - 1674-8301
DOI - 10.7555/jbr.29.20140147
Subject(s) - medicine , cardiology , ventricular tachycardia , ventricular fibrillation , implantable cardioverter defibrillator , fibrillation , heart disease , disease , pharmacotherapy , tachycardia , atrial fibrillation
Electrical storm, defined as 3 or more separate episodes of ventricular tachycardia or ventricular fibrillation within 24 hours, carries significant morbidity and mortality. These unstable ventricular arrhythmias have been described with a variety of conditions including ischemic heart disease, structural heart disease, and genetic conditions. While implantable cardioverter defibrillator implantation and ablation may be indicated and required, antiarrhythmic medication remains an important adjunctive therapy for these persons.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom